GLP-1 drugs fail to provide key long-term health benefit (IMAGE)
Caption
“Cardiorespiratory fitness is a potent predictor of all-cause and cardiovascular mortality risk across a range of populations, including obesity, diabetes and heart failure,” said Siddhartha S. Angadi, PhD, a cardiovascular exercise physiologist with UVA’s Department of Kinesiology. “In a recent study by our group that examined mortality outcomes from almost 400,000 individuals across the world, we found that CRF was far superior to overweight or obesity status for predicting the risk of death. In fact, once CRF was factored in, body weight failed to predict the risk of mortality. This is why it’s so important to understand the effects of this new class of drugs on it.”
Credit
UVA Health
Usage Restrictions
May be used to accompany news coverage of the GLP-1 findings. All other uses require express written consent from UVA Health.
License
Original content